---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020292"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:41:46.776245+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition postpones extraordinary general meeting to May 21; shareholders to vote on extension to Feb 2025

## Summary
- Meeting postponed from May 17 to May 21, 2024 at 9:00 a.m. ET.
- Shareholders will vote on extending business combination deadline from May 23, 2024 to February 17, 2025.
- Redemption deadline extended to May 17, 2024; shareholders can withdraw previously submitted requests.
- No changes to record date, location, or proposals to be voted on.

## SEC filing metadata
- accession: 0001493152-24-020292
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/0001493152-24-020292-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224020292/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020292
- JSON: https://secwatch.observer/filing/0001493152-24-020292.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020292.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.